Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 16;5(6):100884.
doi: 10.1016/j.xops.2025.100884. eCollection 2025 Nov-Dec.

OCT-Defined Atrophic Age-Related Macular Degeneration Changes Associated with Deep Visual Sensitivity Losses: A Multicenter Study

Affiliations

OCT-Defined Atrophic Age-Related Macular Degeneration Changes Associated with Deep Visual Sensitivity Losses: A Multicenter Study

Zhichao Wu et al. Ophthalmol Sci. .

Abstract

Purpose: To identify combination(s) of OCT changes that define atrophic age-related macular degeneration (AMD) lesions associated with repeatable deep visual sensitivity defects.

Design: Reader study.

Participants: One hundred seventy-one OCT scans from 60 eyes of 53 participants.

Methods: Participants underwent 2 high-density targeted microperimetry tests (Macular Integrity Assessment device with Goldmann Size III stimuli) per visit of a 3.5° (approximately 1000 μm) diameter region-of-interest that had evidence of at least incomplete retinal pigment epithelium (RPE) and outer retinal atrophy (iRORA). OCT B-scans within the region sampled on microperimetry were annotated by 12 readers from 6 established reading centers for 7 different features related to RPE and outer retinal atrophy. The prevalence of the presence of a repeatable ≤10 decibel (dB) defect on microperimetry for lesions categorized by 18 different combinations of such features, or criteria, was determined.

Main outcome measures: The criteria for OCT-defined atrophic changes showing a ≥90% prevalence of a repeatable ≤10 dB defect, which has previously shown to be characteristic of regions with a truly nonresponding test location on microperimetry.

Results: Sixty percent of complete RPE and outer retinal atrophy (cRORA) lesions-based on the presence of hypertransmission and RPE abnormalities ≥250 μm in width, with evidence of overlying photoreceptor (PR) degeneration, on an OCT B-scan-had a repeatable ≤10 dB defect. However, between 92% and 98% of lesions with both hypertransmission and complete RPE loss ≥500 μm, and with evidence of any size of any feature of overlying PR degeneration, had a repeatable ≤10 dB defect, depending on the criteria considered. Between 92% and 95% of lesions with hypertransmission ≥500 μm and either overlying external limiting membrane disruption, or outer plexiform layer and inner nuclear layer subsidence, and/or hyporeflective wedge-shaped band(s) ≥500 μm, with or without RPE abnormalities, had a repeatable ≤10 dB defect.

Conclusions: This study identified various criteria for OCT-defined atrophic AMD lesions with functional characteristics that can be expected of regions with a truly nonresponding test location on high-density targeted microperimetry testing (i.e., having a ≥90% prevalence of a repeatable ≤10 dB defect). Such OCT-defined lesions could thus serve as functionally relevant clinical endpoints of end-stage atrophic AMD to facilitate preventative treatment trials.

Financial disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Keywords: Age-related macular degeneration; Geographic atrophy; Microperimetry; Optical coherence tomography; cRORA.

PubMed Disclaimer

Figures

Figure 1
Figure 1
OCT B-scan showing an example with the 7 features associated with atrophy annotated by 1 grader in this study, including: choroidal signal hypertransmission, RPE abnormalities, complete RPE loss, EZ disruption, ELM disruption, ONL thinning, and OPL+INL subsidence and/or hyporeflective wedge-shaped band (graded together as a single feature). ELM = external limiting membrane; EZ = ellipsoid zone; ONL = outer nuclear layer; OPL+INL = outer plexiform layer and inner nuclear layer; RPE = retinal pigment epithelium.
Figure 2
Figure 2
Two examples of lesions showing a repeatable ≤10 dB defect on high-density targeted microperimetry testing, with the number of readers considering atrophic AMD changes to be present based on 5 selected criteria, are shown. The dashed black box on the near-infrared reflectance image (middle column) indicates the location where the 2 microperimetry tests (left column) were performed and where the OCT B-scan (right column) was taken through. AMD = age-related macular degeneration; dB = decibel; ELM = external limiting membrane; hyporeflective wedge = hyporeflective wedge-shaped band(s) within Henle fiber layer; OPL+INL = outer plexiform layer and inner nuclear layer; PR = photoreceptor; RPE = retinal pigment epithelium.
Figure 3
Figure 3
Two examples of lesions without a repeatable ≤10 dB defect on high-density targeted microperimetry testing, with the number of readers considering atrophic AMD changes to be present based on 5 selected criteria, are shown. The dashed black box on the near-infared reflectance image (middle column) indicates the location where the 2 microperimetry tests (left column) were performed and where the OCT B-scan (right column) was taken through. AMD = age-related macular degeneration; dB = decibel; ELM = external limiting membrane; hyporeflective wedge = hyporeflective wedge-shaped band(s) within Henle fiber layer; OPL+INL = outer plexiform layer and inner nuclear layer; PR = photoreceptor; RPE = retinal pigment epithelium.

References

    1. Heier J.S., Lad E.M., Holz F.G., et al. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials. Lancet. 2023;402:1434–1448. - PubMed
    1. Khanani A.M., Patel S.S., Staurenghi G., et al. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial. Lancet. 2023;402:1449–1458. - PubMed
    1. Age-Related Eye Disease Study Research Group A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8. Arch Ophthalmol. 2001;119:1417–1436. - PMC - PubMed
    1. Complications of Age-Related Macular Degeneration Prevention Trial Research Group Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial. Ophthalmology. 2006;113:1974–1986. - PubMed
    1. Friberg T.R., Brennen P.M., Freeman W.R., Musch D.C. Prophylactic treatment of age-related macular degeneration report number 2: 810-nanometer laser to eyes with drusen: bilaterally eligible patients. Ophthalmic Surg Lasers Imaging Retina. 2009;40:530. - PubMed

LinkOut - more resources